OMVOCATE Trademark

Trademark Overview

On Monday, June 2, 2008, a trademark application was filed for OMVOCATE with the United States Patent and Trademark Office. The USPTO has given the OMVOCATE trademark a serial number of 77488593. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 9, 2018. This trademark is owned by AstraZeneca AB. The OMVOCATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
omvocate

General Information

Serial Number77488593
Word MarkOMVOCATE
Filing DateMonday, June 2, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 9, 2018
Registration Number4004223
Registration DateTuesday, August 2, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
Translation of Words in Mark The wording "OMVOCATE" has no meaning in English.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Friday, March 9, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, August 2, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2011PUBLISHED FOR OPPOSITION
Thursday, April 14, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 9, 2011ASSIGNED TO LIE
Tuesday, March 29, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 20, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 20, 2010INQUIRY TO SUSPENSION E-MAILED
Monday, September 20, 2010SUSPENSION INQUIRY WRITTEN
Thursday, March 18, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 16, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, September 16, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 15, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, March 12, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009SUSPENSION LETTER WRITTEN
Thursday, March 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, March 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, March 9, 2009EXAMINER'S AMENDMENT ENTERED
Monday, March 9, 2009ASSIGNED TO LIE
Friday, March 6, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT -WRITTEN
Sunday, September 14, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 14, 2008NON-FINAL ACTION E-MAILED
Sunday, September 14, 2008NON-FINAL ACTION WRITTEN
Friday, September 12, 2008ASSIGNED TO EXAMINER
Thursday, June 5, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

omvocate pharmaceutical treatment preparations disorders diseases diabetes cancer neurological infection psychiatric